Gene: CHST2
Official Full Name: carbohydrate sulfotransferase 2provided by HGNC
Gene Summary: This locus encodes a sulfotransferase protein. The encoded enzyme catalyzes the sulfation of a nonreducing N-acetylglucosamine residue, and may play a role in biosynthesis of 6-sulfosialyl Lewis X antigen. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33236 | CHST2 Knockout cell line (HCT 116) | Human | CHST2 | 1:2~1:4 | Negative | Online Inquiry |
KO33237 | CHST2 Knockout cell line (HEK293) | Human | CHST2 | 1:3~1:6 | Negative | Online Inquiry |
CHST2 Gene Knockout Cell Lines are specifically engineered cellular models that have had the CHST2 gene, which encodes a glycosyltransferase involved in the sulfation of glycosaminoglycans, completely disrupted. By employing the CRISPR-Cas9 genome-editing technology, these cell lines facilitate the deletion of the CHST2 gene, allowing researchers to examine the intricate pathways and biological functions linked to sulfated proteoglycans and their roles in cellular signaling and interaction.
The primary function of the CHST2 Gene Knockout Cell Lines is to serve as a critical tool for elucidating the biological roles of CHST2 and its associated sulfation pathways. This disruption provides researchers with a platform to explore the implications of CHST2 deficiency in various cellular processes, such as cell adhesion, migration, and proliferation. Its importance extends to understanding the pathology of diseases where glycosylation plays a pivotal role, including cancer metastasis and inflammatory responses.
In research and clinical settings, these cell lines have profound scientific value, particularly in therapeutic development and biomarker identification. They allow for high-throughput screening of compounds that could modulate sulfation pathways, providing insights into potential treatments for diseases linked to glycosaminoglycan dysregulation.
The unique selling point of the CHST2 Gene Knockout Cell Lines lies in their precision, reproducibility, and the ability to investigate the gene's function in real-time. Unlike alternatives that may offer only partial or transient gene silencing, these knockout lines ensure complete and stable loss of gene function, providing more reliable data. Additionally, they are suitable for various applications, including functional assays, drug testing, and mechanistic studies.
For researchers and clinicians striving to advance their understanding of cellular mechanisms or develop novel therapies, the CHST2 Gene Knockout Cell Lines present a valuable resource that bridges molecular genetics and practical applications. With our company’s expertise in advanced genomic techniques and unwavering commitment to quality, we deliver cutting-edge tools that empower scientific exploration and innovation in the realm of biology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.